← Back to headlines
LifeMD Targets $250M+ Annualized Revenue by Q4 2026
LifeMD has outlined a target of achieving over $250 million in annualized revenue run rate by the fourth quarter of 2026, driven by record demand for GLP-1 drugs and expanded partnerships.
9 Mar, 22:39 — 9 Mar, 22:39
Sources
Showing 1 of 1 sources
